Victoria Johnson

This February 2025 month in review covers key pulmonology updates, including FDA reviews for brensocatib and PRGN-2012, dupilumab’s COPD data, and wildfire air quality risks.

Chambliss and colleagues found a 1% increase in asthma-related emergency department visits per unit of distance to semiconductor fabrication plants.

Listen Key Takeaways Rural patients with PsA and AS often use emergency departments for non-urgent issues, highlighting healthcare access challenges.

At AAAAI, Golden discussed when to test for insect sting allergies, the role of venom immunotherapy, and the potential impact of epinephrine nasal spray.

Omalizumab-igec is approved in 2 formulations for the treatment of moderate to severe persistent asthma, CRSwNP, IgE-mediated food allergy, and CSU.

Bernstein also discussed other unmet needs in the field and how his center is working to address them.

Lipworth shared findings from 2 studies that he presented data from at the AAAAI/WAO Joint Congress.

A cross-sectional cohort study identified several factors linked to eyewash use among individuals with allergic rhinitis.

Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key dermatology updates from the 2025 American Academy of Allergy, Asthma, and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress.